Mizera et al., in their study on a cohort of individuals with primary antibody deficiencies receiving 2–4 doses, found that anti-SARS-CoV-2 IgG did not correlate with either CD4+ or CD8+ levels, but rather NK cells [108]. Here, CD4 is linked to agammaglobulinemia.